QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (26) Citing Articles via Google Scholar Google Scholar Articles by Besong, G. Articles by Nicoletti, F. Search for Related Content PubMed PubMed Citation Articles by Besong, G. Articles by Nicoletti, F.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 1, 2002, 22(13):5403-5411

Activation of Group III Metabotropic Glutamate Receptors Inhibits the Production of RANTES in Glial Cell Cultures

Gilbert Besong^{1, *}, Giuseppe Battaglia^{1, *}, Mara D'Onofrio^{1, *}, Roberto Di Marco², Richard Teke Ngomba¹, Marianna Storto¹, Marzia Castiglione⁴, Katia Mangano², Carla L. Busceti¹, Ferdinando R. Nicoletti^{2, 3}, Kevin Bacon⁵, Michael Tusche⁵, Ornella Valenti⁶, Peter Jeffrey Conn⁶, Valeria Bruno^{1, 4}, and Ferdinando Nicoletti^{1, 4}

¹ Istituto Neurologico Mediterraneo Neuromed, 86077 Pozzilli, Italy, Departments of ² Microbiology and Gynecology and ³ Biology/Section of General Pathology, University of Catania, 95125 Catania, Italy, ⁴ Department of Human Physiology and Pharmacology, University "La Sapienza", 00185 Rome, Italy, ⁵ Department of Biology, Bayer Yakuhin, Ltd. 6-5-1-3, Kunimidai, Kyoto, Japan, and ⁶ Department of Pharmacology, School of Medicine, Emory University, Atlanta, Georgia 30322

The chemokine RANTES is critically involved in neuroinflammation and has been implicated in the pathophysiology of multiple sclerosis. We examined the possibility that activation of G-protein-coupled metabotropic glutamate (mGlu) receptors regulates the formation of RANTES in glial cells. A 15 hr exposure of cultured astrocytes to tumor necrosis factor- and interferon- induced a substantial increase in both RANTES mRNA and extracellular RANTES levels. These increases were markedly reduced when astrocytes were coincubated with L-2-amino-4-phosphonobutanoate (L-AP-4), 4-phosphonophenylglycine, or L-serine-O-phosphate, which selectively activate group III mGlu receptor subtypes (i.e., mGlu4, -6, -7, and -8 receptors). Agonists of mGlu1/5 or mGlu2/3 receptors were virtually inactive. Inhibition of RANTES release produced by L-AP-4 was attenuated by the selective group III mGlu receptor antagonist (R,S)--methylserine-O-phosphate or by pretreatment of the cultures with pertussis toxin. Cultured astrocytes expressed mGlu4 receptors, and the ability of L-AP-4 to inhibit RANTES release was markedly reduced in cultures prepared from mGlu4 knock-out mice. This suggests that activation of mGlu4 receptors negatively modulates the production of RANTES in glial cells. We also examined the effect of L-AP-4 on the development of experimental allergic encephalomyelitis (EAE) in Lewis rats. L-AP-4 was subcutaneously infused for 28 d by an osmotic minipump that released 250 nl/hr of a solution of 250 mM of the drug. Detectable levels of L-AP-4 (~100 nM) were found in the brain dialysate of EAE rats. Infusion of L-AP-4 did not affect the time at onset and the severity of neurological symptoms but significantly increased the rate of recovery from EAE. In addition, lower levels of RANTES mRNA were found in the cerebellum and spinal cord of EAE rats infused with L-AP-4. These results suggest that pharmacological activation of group III mGlu receptors may be useful in the experimental treatment of neuroinflammatory CNS disorders.

Key words: chemokines; glial cultures; experimental allergic encephalomyelitis; multiple sclerosis; mGlu4 receptor; leukocytes

---

^* G.B., G.B., and. M.D. contributed equally to this work.

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22135403-09$05.00/0

This article has been cited by other articles:

				V. Musante, F. Longordo, E. Neri, M. Pedrazzi, F. Kalfas, P. Severi, M. Raiteri, and A. Pittaluga RANTES Modulates the Release of Glutamate in Human Neocortex J. Neurosci., November 19, 2008; 28(47): 12231 - 12240. [Abstract] [Full Text] [PDF]

				P. Sarchielli, L. Greco, A. Floridi, A. Floridi, and V. Gallai Excitatory Amino Acids and Multiple Sclerosis: Evidence From Cerebrospinal Fluid Arch Neurol, August 1, 2003; 60(8): 1082 - 1088. [Abstract] [Full Text] [PDF]

				J. J. G. Geurts, G. Wolswijk, L. Bo, P. van der Valk, C. H. Polman, D. Troost, and E. Aronica Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis Brain, August 1, 2003; 126(8): 1755 - 1766. [Abstract] [Full Text] [PDF]

				D. L. Taylor, L. T. Diemel, and J. M. Pocock Activation of Microglial Group III Metabotropic Glutamate Receptors Protects Neurons against Microglial Neurotoxicity J. Neurosci., March 15, 2003; 23(6): 2150 - 2160. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help